Don Husereau

Names

Identifer

Contact

Research profile

author of:

• Capturing Value from Health Technologies in Lean Times (RePEc:cdh:commen:396)
  by Ake Blomqvist & Colin Busby & Don Husereau
• A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development (RePEc:plo:pone00:0090434)
  by Lianne Barnieh & Fiona Clement & Anthony Harris & Marja Blom & Cam Donaldson & Scott Klarenbach & Don Husereau & Diane Lorenzetti & Braden Manns
• Economic evaluations of eHealth technologies: A systematic review (RePEc:plo:pone00:0198112)
  by Chiranjeev Sanyal & Paul Stolee & Don Juzwishin & Don Husereau
• Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis (RePEc:plo:pone00:0240584)
  by Jesse Elliott & Amy Johnston & Don Husereau & Shannon E Kelly & Caroline Eagles & Alice Charach & Shu-Ching Hsieh & Zemin Bai & Alomgir Hossain & Becky Skidmore & Eva Tsakonas & Dagmara Chojecki & Muh
• Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB) (RePEc:sae:medema:v:39:y:2019:i:4:p:371-379)
  by Feng Xie & Michael Zoratti & Kelvin Chan & Don Husereau & Murray Krahn & Oren Levine & Tammy Clifford & Holger Schunemann & Gordon Guyatt
• Reporting Economic Evaluations with Value of Information Analyses Using the CHEERS Value of Information (CHEERS-VOI) Reporting Guideline (RePEc:sae:medema:v:44:y:2024:i:2:p:127-128)
  by Natalia Kunst & Annisa Siu & Michael Drummond & Sabine Grimm & Janneke Grutters & Don Husereau & Hendrik Koffijberg & Claire Rothery & Edward C. F. Wilson & Anna Heath
• How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States? (RePEc:spr:aphecp:v:13:y:2015:i:3:p:273-279)
  by Don Husereau & Anthony Culyer & Peter Neumann & Philip Jacobs
• Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation (RePEc:spr:aphecp:v:14:y:2016:i:3:d:10.1007_s40258-016-0229-2)
  by Amy Tawfik & Walter P. Wodchis & Petros Pechlivanoglou & Jeffrey Hoch & Don Husereau & Murray Krahn
• Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching (RePEc:spr:aphecp:v:16:y:2018:i:3:d:10.1007_s40258-018-0371-0)
  by Don Husereau & Brian Feagan & Carl Selya-Hammer
• Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists (RePEc:spr:aphecp:v:18:y:2020:i:3:d:10.1007_s40258-019-00535-x)
  by Chiranjeev Sanyal & Don Husereau
• Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (RePEc:spr:aphecp:v:20:y:2022:i:2:d:10.1007_s40258-021-00704-x)
  by Don Husereau & Michael Drummond & Federico Augustovski & Esther Bekker-Grob & Andrew H. Briggs & Chris Carswell & Lisa Caulley & Nathorn Chaiyakunapruk & Dan Greenberg & Elizabeth Loder & Josephine Ma
• Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (RePEc:spr:aphecp:v:20:y:2022:i:5:d:10.1007_s40258-022-00743-y)
  by Don Husereau & Michael Drummond & Federico Augustovski & Esther Bekker-Grob & Andrew H. Briggs & Chris Carswell & Lisa Caulley & Nathorn Chaiyakunapruk & Dan Greenberg & Elizabeth Loder & Josephine Ma
• Comment on: “Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses” (RePEc:spr:aphecp:v:22:y:2024:i:2:d:10.1007_s40258-023-00856-y)
  by Natalia Kunst & Annisa Siu & Michael Drummond & Sabine Grimm & Janneke Grutters & Don Husereau & Hendrik Koffijberg & Claire Rothery & Edward C. F. Wilson & Anna Heath
• Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (RePEc:spr:eujhec:v:14:y:2013:i:3:p:367-372)
  by Don Husereau & Michael Drummond & Stavros Petrou & Chris Carswell & David Moher & Dan Greenberg & Federico Augustovski & Andrew Briggs & Josephine Mauskopf & Elizabeth Loder
• Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists (RePEc:spr:eujhec:v:22:y:2021:i:5:d:10.1007_s10198-021-01286-0)
  by Michael J. Zoratti & A. Simon Pickard & Peep F. M. Stalmeier & Daniel Ollendorf & Andrew Lloyd & Kelvin K W Chan & Don Husereau & John E. Brazier & Murray Krahn & Mitchell Levine & Lehana Thabane & Fe
• Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations (RePEc:spr:eujhec:v:23:y:2022:i:8:d:10.1007_s10198-021-01426-6)
  by Don Husereau & Michael Drummond & Federico Augustovski & Esther Bekker-Grob & Andrew H. Briggs & Chris Carswell & Lisa Caulley & Nathorn Chaiyakunapruk & Dan Greenberg & Elizabeth Loder & Josephine Ma
• Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement (RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367)
  by Don Husereau & Michael Drummond & Stavros Petrou & Chris Carswell & David Moher & Dan Greenberg & Federico Augustovski & Andrew Briggs & Josephine Mauskopf & Elizabeth Loder
• Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration (RePEc:spr:pharme:v:33:y:2015:i:5:p:535-536)
  by Don Husereau & Michael Drummond & Stavros Petrou & Dan Greenberg & Josephine Mauskopf & Federico Augustovski & Andrew Briggs & David Moher & Elizabeth Loder & Chris Carswell
• Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment (RePEc:spr:pharme:v:36:y:2018:i:1:d:10.1007_s40273-017-0583-4)
  by Jaclyn Beca & Don Husereau & Kelvin K. W. Chan & Neil Hawkins & Jeffrey S. Hoch
• Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT) (RePEc:spr:pharme:v:39:y:2021:i:9:d:10.1007_s40273-021-01039-0)
  by Michael J. Zoratti & Kelvin K. W. Chan & Don Husereau & Murray Krahn & Mitchell Levine & Lehana Thabane & Feng Xie
• Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (RePEc:spr:pharme:v:40:y:2022:i:6:d:10.1007_s40273-021-01112-8)
  by Don Husereau & Michael Drummond & Federico Augustovski & Esther Bekker-Grob & Andrew H. Briggs & Chris Carswell & Lisa Caulley & Nathorn Chaiyakunapruk & Dan Greenberg & Elizabeth Loder & Josephine Ma